Wright Medical Group N.V. (NASDAQ:WMGI)‘s stock had its “buy” rating reaffirmed by Robert W. Baird in a research report issued on Friday. They presently have a $33.00 price target on the medical device company’s stock. Robert W. Baird’s target price suggests a potential upside of 19.96% from the company’s current price.

Several other equities research analysts have also recently issued reports on the company. Cantor Fitzgerald started coverage on Wright Medical Group N.V. in a research note on Thursday, June 29th. They issued an “overweight” rating and a $33.00 price target for the company. Oppenheimer Holdings, Inc. set a $30.00 price target on Wright Medical Group N.V. and gave the company a “hold” rating in a research note on Thursday, August 3rd. BidaskClub cut Wright Medical Group N.V. from a “hold” rating to a “sell” rating in a research note on Saturday, June 10th. Needham & Company LLC reiterated a “hold” rating on shares of Wright Medical Group N.V. in a research note on Friday, September 1st. Finally, Jefferies Group LLC reiterated a “buy” rating and issued a $33.00 price target on shares of Wright Medical Group N.V. in a research note on Friday, August 4th. Six equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $32.20.

Shares of Wright Medical Group N.V. (NASDAQ WMGI) traded up 1.29% during trading on Friday, hitting $27.51. The stock had a trading volume of 1,142,999 shares. The stock’s market capitalization is $2.87 billion. Wright Medical Group N.V. has a 12-month low of $20.50 and a 12-month high of $31.53. The stock’s 50-day moving average is $27.57 and its 200-day moving average is $28.06.

Wright Medical Group N.V. (NASDAQ:WMGI) last issued its quarterly earnings results on Wednesday, August 2nd. The medical device company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.02. The business had revenue of $179.69 million during the quarter, compared to analysts’ expectations of $178.17 million. Wright Medical Group N.V. had a negative return on equity of 6.22% and a negative net margin of 36.04%. The firm’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.11) earnings per share. Analysts predict that Wright Medical Group N.V. will post ($0.29) EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Wright Medical Group N.V. (WMGI) Receives Buy Rating from Robert W. Baird” was originally published by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another website, it was illegally copied and republished in violation of United States & international trademark & copyright legislation. The correct version of this story can be accessed at https://www.watchlistnews.com/wright-medical-group-n-v-wmgi-receives-buy-rating-from-robert-w-baird/1613839.html.

In other Wright Medical Group N.V. news, SVP Jennifer S. Walker sold 20,000 shares of the business’s stock in a transaction that occurred on Wednesday, July 19th. The shares were sold at an average price of $28.00, for a total transaction of $560,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 9.30% of the stock is owned by insiders.

Several large investors have recently made changes to their positions in the company. FMR LLC increased its holdings in shares of Wright Medical Group N.V. by 5.7% during the second quarter. FMR LLC now owns 15,644,806 shares of the medical device company’s stock worth $430,075,000 after buying an additional 845,909 shares in the last quarter. Vanguard Group Inc. increased its holdings in shares of Wright Medical Group N.V. by 1.8% during the second quarter. Vanguard Group Inc. now owns 8,232,880 shares of the medical device company’s stock worth $226,321,000 after buying an additional 145,930 shares in the last quarter. Capital Research Global Investors increased its holdings in shares of Wright Medical Group N.V. by 60.9% during the second quarter. Capital Research Global Investors now owns 2,775,000 shares of the medical device company’s stock worth $76,285,000 after buying an additional 1,050,000 shares in the last quarter. Palo Alto Investors LLC increased its holdings in shares of Wright Medical Group N.V. by 1.8% during the second quarter. Palo Alto Investors LLC now owns 2,676,393 shares of the medical device company’s stock worth $73,574,000 after buying an additional 48,200 shares in the last quarter. Finally, Janus Henderson Group PLC acquired a new position in shares of Wright Medical Group N.V. during the second quarter worth $68,618,000.

About Wright Medical Group N.V.

Wright Medical Group, Inc is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic.

Analyst Recommendations for Wright Medical Group N.V. (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.